You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

Article metrics

Article menu
Immunotherapy biomarkers
Original research
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

 

Online download statistics by month:

Online download statistics by month: March 2022 to July 2025

AbstractFullPdf
Feb 2022723774456
Mar 2022350374178
Apr 202218318772
May 202216117067
Jun 202218019363
Jul 202216417136
Aug 202218218864
Sep 202216416851
Oct 202217618443
Nov 202214815163
Dec 202211211423
Jan 202312012734
Feb 202314714740
Mar 2023869051
Apr 2023798058
May 2023858534
Jun 2023687022
Jul 2023636524
Aug 2023394022
Sep 2023646417
Oct 2023272711
Nov 2023515121
Dec 2023363826
Jan 2024434325
Feb 2024535331
Mar 2024737343
Apr 2024676824
May 2024595927
Jun 2024798034
Jul 202410010235
Aug 2024575721
Sep 2024626231
Oct 2024626525
Nov 2024818427
Dec 2024747536
Jan 2025828227
Feb 2025939331
Mar 2025757545
Apr 2025717130
May 2025979936
Jun 2025373730
Jul 2025110
Total467448372034